Author(s)

Sanra Déborah Sanogo^1*, Moussa Y. Dicko², Lamine N’Diaye³, Ousmane Diarra³, Drissa Katilé², Abdoulaye Maiga¹, Ouatou Mallé¹, Sabine Drabo¹, Makan S. Tounkara², Hourouma Sow², Kadiatou Doumbia², Anselme Konaté², Moussa T. Diarra²

¹Hepato-Gastroenterology Department, Centre Hospitalier Universitaire Du Point G, Bamako, Mali.
²Hepato-Gastroenterology Department, Gabriel Toure University Hospital, Bamako, Mali.
³Hepato-Gastroenterology Unit, Csref Commune V, Bamako, Mali.

Chronic hepatitis B causes a liver disease characterized by inflammation of the liver parenchyma. The aim of this study was to investigate the evolution of biological parameters in patients treated with Tenofovir for chronic B infection at the Commune V referral health center in Bamako. We obtained a prevalence of 14.15%. The most represented age group was 31 - 40 years, with 36.8%. The sex ratio was 1.44 in favour of men. Viral load was undetectable after 18 months of treatment in 25 patients (42.37%). Tenofovir, the 1st-line drug in Mali, is effective on the biological parameters monitored in patients.

Viral Hepatitis B, Tenofovir, Biological Parameters

Sanogo, S. , Dicko, M. , N’Diaye, L. , Diarra, O. , Katilé, D. , Maiga, A. , Mallé, O. , Drabo, S. , Tounkara, M. , Sow, H. , Doumbia, K. , Konaté, A. and Diarra, M. (2024) Chronic Hepatitis B Virus Infection: Biological Parameters in Patients Treated with Tenofovir Disoproxil Fumarate. Open Journal of Gastroenterology, 14, 145-151. doi: 10.4236/ojgas.2024.144016.